Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
UN Aids target to end epidemic by 2030 at risk as funding falls for first time

The pace of reducing new HIV infections is slowing and progress in accessing treatment is decreasing, putting UN targets to end the Aids epidemic by 2030 in doubt.

Published
11 hours ago
From
The Guardian
No new cases of HIV among people in Wales taking PrEP

Vaughan Gething, the Welsh minister for health and social services, said he was “delighted” that access to PrEP was now “fully embedded” into sexual health services.

Published
11 hours ago
From
The Pharmaceutical Journal
Market for HIV Prevention Drugs May More Than Double, Citi Says

An experimental drug from Merck & Co may lead the way in the U.S. market, Citi said. Baum estimates MK-8591 may reach sales of $7 billion in HIV. Of that total, $3.5 billion may come from pre-exposure prophylaxis, or PrEP, as the preventative treatments are called.

Published
12 hours ago
From
Bloomberg
The New Face of HIV and Treating the 'Hardly Reached'

Physicians, scientists, government agencies, and companies are questioning whether the way they've always recruited for clinical trials still serves patients.

Published
23 hours ago
From
Medscape (requires free registration)
The Beautiful Uncertainty of Douglas Crimp

Masha Gessen mourns critic, curator, and art historian Douglas Crimp as a prominent voice in AIDS activism by way of two classic Crimp essays: “How to Have Promiscuity in an Epidemic” and “Mourning and Militancy.”

Published
17 July 2019
From
New Yorker
Kaiser/UNAIDS analysis finds donor governments spent US$8 billion for HIV in 2018, similar to a decade ago

Donor government disbursements to combat HIV in low- and middle-income countries totaled US$8 billion in 2018, little changed from the US$8.1 billion total in 2017 and from the levels of a decade ago, finds a new report from the Kaiser Family Foundation (KFF) and the Joint United Nations Programme on HIV/AIDS (UNAIDS).

Published
17 July 2019
From
UNAIDS press release
Is It Safe to Interrupt HIV Treatment During Cure Studies?

Previous research has shown that long interruptions are not safe—but what about shorter, more closely monitored gaps in treatment?

Published
17 July 2019
From
POZ
UNAIDS calls for greater urgency as global gains slow and countries show mixed results towards 2020 HIV targets

The pace of progress in reducing new HIV infections, increasing access to treatment and ending AIDS-related deaths is slowing down according to a new report released today by UNAIDS. 

Published
17 July 2019
From
UNAIDS press release
HIV Vaccine Trials on Gay, Bi Men to Begin in U.S., Europe

Around 3800 men who have sex with men will be part of Johnson & Johnson's historic vaccine trial.

Published
15 July 2019
From
Advocate.com
Adults with HIV who have compassionate care providers start and remain in treatment longer

Researchers find patients who perceive their primary care providers as lacking empathy and not willing to include them in decision making are at risk for abandoning treatment or not seeking treatment at all.

Published
15 July 2019
From
ScienceDaily
← First12345...566Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.